DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Randall J Bateman, MD
Washington University School of Medicine
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Neuroscience Research Australia
Randwick, New South Wales, Australia
- the National Hospital for Neurology and Neurosurgery
London, Greater London, United Kingdom
- University of Alabama in Birmingham
Birmingham, Alabama, United States
- Indiana University School of Medicine
Indianapolis, Indiana, United States
- Washington University in St. Louis
St Louis, Missouri, United States
- University of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Jun 2024
- Primary completion
- 30 Jun 2030
- Completion
- 30 Jun 2030
- Last update posted
- 5 Mar 2026
- Registered enrollment
- 40
- Registry id
- NCT06384573
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.